Tumour suppressor p16 INK4a – anoikis‐favouring decrease in N/O‐glycan/cell surface sialylation by down‐regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model

Tumour suppressor p16 INK4a is known to exert cell‐cycle control via cyclin‐dependent kinases. An emerging aspect of its functionality is the orchestrated modulation of N / O ‐glycosylation and galectin expression to induce anoikis in human C apan‐1 pancreatic carcinoma cells. Using chemoselectiv…